Cuprina Holdings (Cayman) Common Stock Net 1970-1969 | CUPR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Cuprina Holdings (Cayman) common stock net from 1970 to 1969. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Cuprina Holdings (Cayman) common stock net from 1970 to 1969. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
AstraZeneca (AZN)	$245.4B
Amgen (AMGN)	$157.5B
Gilead Sciences (GILD)	$146.4B
Vertex Pharmaceuticals (VRTX)	$100B
Bristol Myers Squibb (BMY)	$98.1B
CSL (CSLLY)	$85.5B
GSK (GSK)	$79.6B
Regeneron Pharmaceuticals (REGN)	$60.8B
Alnylam Pharmaceuticals (ALNY)	$59.9B
Argenex SE (ARGX)	$40.5B
BioNTech SE (BNTX)	$27.1B
Insmed (INSM)	$26.9B
Royalty Pharma (RPRX)	$20.9B
Biogen (BIIB)	$19.9B
Incyte (INCY)	$16.6B
Illumina (ILMN)	$15.5B
Genmab (GNMSF)	$15.3B
Genmab (GMAB)	$15B
Ascendis Pharma (ASND)	$11.9B
BioMarin Pharmaceutical (BMRN)	$11B
Moderna (MRNA)	$10.9B
QIAGEN (QGEN)	$10.8B
Swedish Orphan Biovitrum (BIOVF)	$10.3B
Exelixis (EXEL)	$10.2B
Verona Pharma American Depositary Share (VRNA)	$9B
Exact Sciences (EXAS)	$8.5B
Bio-Techne Corp (TECH)	$8.4B
Blueprint Medicines (BPMC)	$8.3B
Halozyme Therapeutics (HALO)	$8.1B
Roivant Sciences (ROIV)	$8B